http://142-54-23-223.fusionmedialtd.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 02 Jul 2026 16:05:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://142-54-23-223.fusionmedialtd.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jul+01++Filed+by%3A+Raykov+Rosty/26727542.html si-local-file:///var/storage/secattach/20260702/26727542.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jul+01++Filed+by%3A+Raykov+Rosty/26727542.html Thu, 02 Jul 2026 16:05:00 -0400 FENC O.21047090 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jul+01++Filed+by%3A+Raykov+Rosty/26727542.html si-local-file:///var/storage/secattach/20260702/26727542.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jul+01++Filed+by%3A+Raykov+Rosty/26727542.html Thu, 02 Jul 2026 16:05:00 -0400 FENC O.21047090 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Evans+Terry+L/26721509.html si-local-file:///var/storage/secattach/20260701/26721509.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Evans+Terry+L/26721509.html Wed, 01 Jul 2026 16:39:00 -0400 FENC O.21047090 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Evans+Terry+L/26721509.html si-local-file:///var/storage/secattach/20260701/26721509.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Evans+Terry+L/26721509.html Wed, 01 Jul 2026 16:39:00 -0400 FENC O.21047090 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Sayad+Pierre+Sargis/26721469.html si-local-file:///var/storage/secattach/20260701/26721469.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Sayad+Pierre+Sargis/26721469.html Wed, 01 Jul 2026 16:37:00 -0400 FENC O.21047090 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Sayad+Pierre+Sargis/26721469.html si-local-file:///var/storage/secattach/20260701/26721469.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Sayad+Pierre+Sargis/26721469.html Wed, 01 Jul 2026 16:37:00 -0400 FENC O.21047090 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Hackman+Jeffrey+S./26721443.html si-local-file:///var/storage/secattach/20260701/26721443.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Hackman+Jeffrey+S./26721443.html Wed, 01 Jul 2026 16:36:00 -0400 FENC O.21047090 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Hackman+Jeffrey+S./26721443.html si-local-file:///var/storage/secattach/20260701/26721443.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Hackman+Jeffrey+S./26721443.html Wed, 01 Jul 2026 16:36:00 -0400 FENC O.21047090 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Andrade+Robert/26721408.html si-local-file:///var/storage/secattach/20260701/26721408.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Andrade+Robert/26721408.html Wed, 01 Jul 2026 16:35:00 -0400 FENC O.21047090 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Andrade+Robert/26721408.html si-local-file:///var/storage/secattach/20260701/26721408.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Andrade+Robert/26721408.html Wed, 01 Jul 2026 16:35:00 -0400 FENC O.21047090 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Cioffi+Christiana+Marie/26721372.html si-local-file:///var/storage/secattach/20260701/26721372.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Cioffi+Christiana+Marie/26721372.html Wed, 01 Jul 2026 16:34:00 -0400 FENC O.21047090 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Cioffi+Christiana+Marie/26721372.html si-local-file:///var/storage/secattach/20260701/26721372.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+30++Filed+by%3A+Cioffi+Christiana+Marie/26721372.html Wed, 01 Jul 2026 16:34:00 -0400 FENC O.21047090 http://www.streetinsider.com/SEC+Filings/Form++144++++++++FENNEC+PHARMACEUTICALS+++++++++++++++++Filed+by%3A+Raykov+Rosty/26721191.html si-local-file:///var/storage/secattach/20260701/26721191.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++FENNEC+PHARMACEUTICALS+++++++++++++++++Filed+by%3A+Raykov+Rosty/26721191.html Wed, 01 Jul 2026 16:30:00 -0400 FENC O.21047090 http://www.streetinsider.com/SEC+Filings/Form++144++++++++FENNEC+PHARMACEUTICALS+++++++++++++++++Filed+by%3A+Raykov+Rosty/26721191.html si-local-file:///var/storage/secattach/20260701/26721191.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++FENNEC+PHARMACEUTICALS+++++++++++++++++Filed+by%3A+Raykov+Rosty/26721191.html Wed, 01 Jul 2026 16:30:00 -0400 FENC O.21047090 http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26669185.html <p align="justify">RESEARCH TRIANGLE PARK, N.C., June 22, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 15,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 22, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26669185.html Mon, 22 Jun 2026 06:00:00 -0400 FENC FRX O.21047090 http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26669185.html <p align="justify">RESEARCH TRIANGLE PARK, N.C., June 22, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 15,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 22, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26669185.html Mon, 22 Jun 2026 06:00:00 -0400 FENC FRX O.21047090 http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26669185.html <p align="justify">RESEARCH TRIANGLE PARK, N.C., June 22, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 15,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 22, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26669185.html Mon, 22 Jun 2026 06:00:00 -0400 FENC FRX O.21047090 http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26669185.html <p align="justify">RESEARCH TRIANGLE PARK, N.C., June 22, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 15,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 22, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26669185.html Mon, 22 Jun 2026 06:00:00 -0400 FENC FRX O.21047090 http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26669185.html <p align="justify">RESEARCH TRIANGLE PARK, N.C., June 22, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 15,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 22, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26669185.html Mon, 22 Jun 2026 06:00:00 -0400 FENC FRX O.21047090 http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26669185.html <p align="justify">RESEARCH TRIANGLE PARK, N.C., June 22, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 15,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 22, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26669185.html Mon, 22 Jun 2026 06:00:00 -0400 FENC FRX O.21047090 http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html <p align="justify">RESEARCH TRIANGLE PARK, N.C., June 15, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 10,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 15, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html Mon, 15 Jun 2026 06:00:00 -0400 FENC FRX O.21047090 http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html <p align="justify">RESEARCH TRIANGLE PARK, N.C., June 15, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 10,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 15, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html Mon, 15 Jun 2026 06:00:00 -0400 FENC FRX O.21047090 http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html <p align="justify">RESEARCH TRIANGLE PARK, N.C., June 15, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 10,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 15, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html Mon, 15 Jun 2026 06:00:00 -0400 FENC FRX O.21047090 http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html <p align="justify">RESEARCH TRIANGLE PARK, N.C., June 15, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 10,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 15, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html Mon, 15 Jun 2026 06:00:00 -0400 FENC FRX O.21047090 http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html <p align="justify">RESEARCH TRIANGLE PARK, N.C., June 15, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 10,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 15, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html Mon, 15 Jun 2026 06:00:00 -0400 FENC FRX O.21047090